MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Perrigo Co PLC

Fermé

SecteurSoins de santé

26.87 -3.69

Résumé

Variation du prix de l'action

24h

Actuel

Min

26.81

Max

27.9

Chiffres clés

By Trading Economics

Revenu

-24M

-45M

Ventes

51M

1.1B

P/E

Moyenne du Secteur

2,570

63.778

BPA

0.93

Rendement du dividende

4.14

Marge bénéficiaire

-3.909

Employés

8,379

EBITDA

35M

114M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+19.42% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.14%

2.39%

Prochains Résultats

6 mai 2025

Date du Prochain Dividende

17 juin 2025

Date du Prochain Détachement de Dividende

29 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

459M

3.8B

Ouverture précédente

30.56

Clôture précédente

26.87

Sentiment de l'Actualité

By Acuity

35%

65%

122 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Perrigo Co PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 févr. 2025, 17:42 UTC

Principaux Mouvements du Marché

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27 févr. 2025, 23:52 UTC

Résultats

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Comparaison

Variation de prix

Perrigo Co PLC prévision

Objectif de Prix

By TipRanks

19.42% hausse

Prévisions sur 12 Mois

Moyen 33.33 USD  19.42%

Haut 42 USD

Bas 27 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

4 ratings

1

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

27.74 / 28.055Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Strong Bullish Evidence

Sentiment

By Acuity

122 / 386Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.